Homepage
Medication Guide
What are the Precautions for Taking Epalrestat?
Epalrestat is an aldose reductase inhibitor. Since its approval in Japan in 1992, it has been widely used as an adjuvant treatment for diabetic peripheral neuropathy.What are the Precautions for Takin...
509
Monday, November 17th, 2025, 09:18
Dosage and Administration of Epalrestat: Recommended Dosage
Epalrestat is a selective aldose reductase inhibitor. Since its approval in Japan in 1992, it has become an important therapeutic agent for diabetic peripheral neuropathy.Dosage and Administration of ...
511
Friday, November 14th, 2025, 14:02
What Are the Indications of Epalrestat?
Epalrestat is an aldose reductase inhibitor that holds an important position in the treatment of diabetic complications. Since its first approval in Japan in 1992, it has become one of the key medicat...
507
Friday, November 14th, 2025, 13:28
Procurement Channels for Epalrestat
Epalrestat is an aldose reductase inhibitor that was first approved in Japan in 1992. It is mainly used for the treatment of diabetic peripheral neuropathy. Its mechanism of action involves inhibiting...
509
Friday, November 14th, 2025, 13:24
What Are the Precautions for Taking Dimemorfan Phosphate Tablets (Astomin)?
Dimemorfan Phosphate Tablets (Astomin) are a type of non-narcotic central antitussive. Since its first approval in Japan in 1975, it has been widely used to relieve cough symptoms in adults due to its...
505
Friday, November 14th, 2025, 13:19
What Are the Indications of Dimemorfan Phosphate Tablets (Astomin)?
Dimemorfan Phosphate Tablets (Astomin) are non-narcotic central antitussives. Owing to their low side effects and low addictiveness, they exhibit unique value in clinical practice.What Are the Indicat...
508
Friday, November 14th, 2025, 13:12
What Are the Side Effects of Enasidenib?
Enasidenib is a targeted medication for isocitrate dehydrogenase-2 (IDH2) mutations, indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML). As a prescription-only drug,...
511
Friday, November 14th, 2025, 11:20
What are the Precautions for Taking Enasidenib?
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor that provides a targeted treatment option for patients with relapsed or refractory acute myeloid leukemia (AML).What are the Precautions fo...
504
Friday, November 14th, 2025, 10:37
Dosage and Administration of Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leuke...
505
Friday, November 14th, 2025, 10:34
Indications for Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) with specific gene mutation types.Indications for Enasid...
507
Friday, November 14th, 2025, 10:31
56 / 207
2065 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved